Intrathecal drug therapy for long-term pain management (Q34008348)

30 July 2017

1 reference

title

Intrathecal drug therapy for long-term pain management (English)

1 reference

30 July 2017

0 references

Virginia L Ghafoor

1

1 reference

30 July 2017

Mikhail Epshteyn

2

1 reference

30 July 2017

Gary H Carlson

3

1 reference

30 July 2017

Donald M Terhaar

4

1 reference

30 July 2017

Orlando Charry

5

1 reference

30 July 2017

Pamela K Phelps

6

1 reference

30 July 2017

publication date

1 December 2007

1 reference

American Journal of Health-System Pharmacy

30 July 2017

published in

1 reference

30 July 2017

volume

64

1 reference

30 July 2017

issue

23

1 reference

30 July 2017

page(s)

2447-2461

1 reference

Clinical guidelines for intraspinal infusion: report of an expert panel. PolyAnalgesic Consensus Conference 2000.

30 July 2017

cites work

1 reference

Polyanalgesic Consensus Conference 2003: an update on the management of pain by intraspinal drug delivery-- report of an expert panel

31 March 2020

1 reference

Understanding the physiology and pharmacology of epidural and intrathecal opioids

31 March 2020

1 reference

Spinal descent of cerebrospinal fluid in man.

31 March 2020

1 reference

Epidural and intrathecal analgesia is effective in treating refractory cancer pain

31 March 2020

1 reference

Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survival

31 March 2020

1 reference

Implantable drug delivery systems (IDDS) after failure of comprehensive medical management (CMM) can palliate symptoms in the most refractory cancer pain patients

31 March 2020

1 reference

Evaluation of patients for implantable pain modalities: medical and behavioral assessment

31 March 2020

1 reference

Clinical realities and economic considerations: Patient selection in intrathecal therapy

31 March 2020

1 reference

Neuraxial medication delivery: the development and maturity of a concept for treating chronic pain of spinal origin

31 March 2020

1 reference

Clinical realities and economic considerations: Economics of intrathecal therapy

31 March 2020

1 reference

Intrathecal morphine for chronic benign pain

31 March 2020

1 reference

The role of intrathecal drugs in the treatment of acute pain

31 March 2020

1 reference

Location, location, location

31 March 2020

1 reference

Intrathecal opioid treatment for chronic non-malignant pain: a 3-year prospective study

31 March 2020

1 reference

Outcome of intrathecal opioids in chronic non-cancer pain

31 March 2020

1 reference

Response of intractable pain to continuous intrathecal morphine: a retrospective study

31 March 2020

1 reference

The efficacy of intrathecal morphine and clonidine in the treatment of pain after spinal cord injury

31 March 2020

1 reference

Long-term outcomes during treatment of chronic pain with intrathecal clonidine or clonidine/opioid combinations

31 March 2020

1 reference

Long-term intrathecal infusion of drug combinations for chronic back and leg pain.

31 March 2020

1 reference

A prospective study of long-term intrathecal morphine in the management of chronic nonmalignant pain

31 March 2020

1 reference

Continuous intrathecal morphine treatment for chronic pain of nonmalignant etiology: long-term benefits and efficacy

31 March 2020

1 reference

Intrathecal hydromorphone for chronic nonmalignant pain: a retrospective study

31 March 2020

1 reference

Intrathecal hydromorphone for intractable nonmalignant pain: a retrospective study

31 March 2020

1 reference

A review of intrathecal fentanyl and sufentanil for the treatment of chronic pain

31 March 2020

1 reference

Long-term effects of continuous intrathecal opioid treatment in chronic pain of nonmalignant etiology

31 March 2020

1 reference

Endocrine consequences of long-term intrathecal administration of opioids

31 March 2020

1 reference

Hypogonadism in patients treated with intrathecal morphine

31 March 2020

1 reference

Hyperalgesia and myoclonus with intrathecal infusion of high-dose morphine

31 March 2020

1 reference

Myoclonic seizure activity with chronic high-dose spinal opioid administration

31 March 2020

1 reference

Meniere-like syndrome following epidural morphine analgesia

31 March 2020

1 reference

Epidural opioids as a cause of vertical nystagmus

31 March 2020

1 reference

Intrathecal infusional analgesia for nonmalignant pain: analgesic efficacy of intrathecal opioid with or without bupivacaine

31 March 2020

1 reference

Long-term intrathecal morphine and bupivacaine in patients with refractory cancer pain. Results from a morphine:bupivacaine dose regimen of 0.5:4.75 mg/ml.

31 March 2020

1 reference

Intrathecal coadministration of bupivacaine diminishes morphine dose progression during long-term intrathecal infusion in cancer patients

31 March 2020

1 reference

Efficacy of intrathecal bupivacaine: how important is the flow rate?

31 March 2020

1 reference

Efficacy and technical complications of long-term continuous intraspinal infusions of opioid and/or bupivacaine in refractory nonmalignant pain: a comparison between the epidural and the intrathecal approach with externalized or implanted catheters

31 March 2020

1 reference

Should intrathecal lidocaine be used in the 21st century?

31 March 2020

1 reference

Long-term intrathecal administration of midazolam and clonidine

31 March 2020

1 reference

Epidural clonidine analgesia for intractable cancer pain. The Epidural Clonidine Study Group

31 March 2020

1 reference

Ziconotide, an intrathecally administered N-type calcium channel antagonist for the treatment of chronic pain

31 March 2020

1 reference

Calcium and sodium channel antagonists for the treatment of pain

31 March 2020

1 reference

Effects of antagonists to high-threshold calcium channels upon spinal mechanisms of pain, hyperalgesia and allodynia

31 March 2020

1 reference

A randomized, double-blind, placebo-controlled study of intrathecal ziconotide in adults with severe chronic pain

31 March 2020

1 reference

A Consensus Statement Regarding the Present Suggested Titration for Prialt (Ziconotide)

31 March 2020

1 reference

Effects of intrathecal baclofen on chronic spinal cord injury pain

31 March 2020

1 reference

Intrathecal baclofen is analgesic in patients with chronic pain

31 March 2020

1 reference

Intrathecal baclofen withdrawal mimicking sepsis

31 March 2020

1 reference

Neuraxial drug administration: a review of treatment options for anaesthesia and analgesia

31 March 2020

1 reference

Management of intrathecal catheter-tip inflammatory masses: a consensus statement

31 March 2020

1 reference

Spinal cord lesion after long-term intrathecal clonidine and bupivacaine treatment for the management of intractable pain

31 March 2020

1 reference

Neurologic complications including paralysis after a medication error involving implanted intrathecal catheters

31 March 2020

1 reference

Encapsulation of an intrathecal catheter

31 March 2020

1 reference

Prevention of intrathecal drug delivery catheter-related complications

31 March 2020

1 reference

Prevention and management of intrathecal drug delivery and spinal cord stimulation system infections

31 March 2020

1 reference

Abrupt withdrawal from intrathecal baclofen: recognition and management of a potentially life-threatening syndrome

31 March 2020

1 reference

Delayed complications of discontinuation of intrathecal baclofen therapy: resurgence of dyssynergic voiding, which triggered off autonomic dysreflexia and hydronephrosis

31 March 2020

1 reference

Pruritus after intrathecal baclofen withdrawal: A retrospective study

31 March 2020

1 reference

A benefit-risk assessment of baclofen in severe spinal spasticity.

31 March 2020

1 reference

Withdrawal symptoms in a patient receiving intrathecal morphine via an infusion pump

31 March 2020

1 reference

Correlation between withdrawal symptoms and medication pump residual volume in patients with implantable SynchroMed pumps

31 March 2020

1 reference

Stability of admixture containing morphine sulfate, bupivacaine hydrochloride, and clonidine hydrochloride in an implantable infusion system

31 March 2020

1 reference

Stability and compatibility of hydromorphone hydrochloride in an implantable infusion system

31 March 2020

1 reference

Stability, compatibility, and safety of intrathecal bupivacaine administered chronically via an implantable delivery system

31 March 2020

1 reference

Stability and Compatibility of Morphine-Clonidine Admixtures in an Implantable Infusion System

31 March 2020

1 reference

Stability of clonidine in clonidine-hydromorphone mixture from implanted intrathecal infusion pumps in chronic pain patients

31 March 2020

1 reference

Calculation methods for the continuous intrathecal infusion of a solution containing two or three drugs

31 March 2020

1 reference

Massive hydromorphone dose delivered subcutaneously instead of intrathecally: guidelines for prevention and management of opioid, local anesthetic, and clonidine overdose.

31 March 2020

1 reference

31 March 2020

Identifiers

DOI

10.2146/AJHP060204

1 reference

30 July 2017

1 reference